102
Views
14
CrossRef citations to date
0
Altmetric
Original Research

MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1

, , , &
Pages 6755-6764 | Published online: 22 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhiying Zhang, Rui Zhang & Donghai Li. (2023) Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer. Biologics: Targets and Therapy 17, pages 113-128.
Read now
Fachen Zhou, Jin Wang, Xinming Chi, Xin Zhou & Zhou Wang. (2020) lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells. Cancer Management and Research 12, pages 5527-5536.
Read now

Articles from other publishers (12)

Kavya V. Anilkumar, L.P. Rema, Mithun Chacko John, T. Vanesa John & Alex George. (2023) miRNAs in the prognosis of triple-negative breast cancer: A review. Life Sciences 333, pages 122183.
Crossref
Kamali Chakkaravarthi, Rajashree Ramesh, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Sandhiya Viswanathan, Mugip Rahaman Abdul Wahab, Hemapreethi Surendran, Maddaly Ravi & Asha Sivaji. (2023) Prospectives of mirna gene signaling pathway in triple-negative breast cancer. Pathology - Research and Practice 248, pages 154658.
Crossref
Brahim El Hejjioui, Salma Lamrabet, Sarah Amrani Joutei, Nadia Senhaji, Touria Bouhafa, Moulay Abdelilah Malhouf, Sanae Bennis & Laila Bouguenouch. (2023) New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer. Diagnostics 13:11, pages 1949.
Crossref
Nur Syafiqah Rahim, Yuan Seng Wu, Maw Shin Sim, Appalaraju Velaga, Srinivasa Reddy Bonam, Subash C. B. Gopinath, Vetriselvan Subramaniyan, Ker Woon Choy, Sin-Yeang Teow, Ismail M. Fareez, Chandramathi Samudi, Shamala Devi Sekaran, Mahendran Sekar & Rhanye Mac Guad. (2023) Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance. Pharmaceuticals 16:1, pages 110.
Crossref
GDeepthi Reddy, V Brahmaiah, BY Kavitha, Jayalatha Nethagani, ElizabethCaroline Palaparthi, RajasekharReddy Lebaka & G Deepika. (2023) Role of epigenetics variation with focus on DNA methylation in triple-negative breast cancer patients. Archives of Medicine and Health Sciences 11:1, pages 96.
Crossref
Leila Bahari Khasraghi, Morteza Nouri, Masoud Vazirzadeh, Nasrin Hashemipour, Mehrdad Talebi, Fatemehsadat Aghaei Zarch, Jamal Majidpoor, Kambiz Kalhor, Poopak Farnia, Sajad Najafi & Seyed Mohsen Aghaei Zarch. (2023) MicroRNA-206 in human cancer: Mechanistic and clinical perspectives. Cellular Signalling 101, pages 110525.
Crossref
Jie Chen, Jin Zhu, Shuai-Jun Xu, Jun Zhou, Xiao-Fei Ding, Yong Liang, Guang Chen & Hong-Sheng Lu. (2022) Transmembrane 4 L Six Family Member 1 Suppresses Hormone Receptor-–Positive, HER2-Negative Breast Cancer Cell Proliferation. Frontiers in Pharmacology 13.
Crossref
Chengzhi He, Wenjing Qi & Zhihui Wang. (2021) Effect and mechanism of downregulating the long-chain noncoding RNA TM4SF1-AS1 on the proliferation, apoptosis and invasion of gastric cancer cells. World Journal of Surgical Oncology 19:1.
Crossref
Ruoqin Wang, Linqing Sun, Suhua Xia, Hongya Wu, Yanchao Ma, Shenghua Zhan, Guangbo Zhang, Xueguang Zhang, Tongguo Shi & Weichang Chen. (2021) B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway. Cell Death & Disease 12:5.
Crossref
Amal Qattan. (2020) Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease. International Journal of Molecular Sciences 21:23, pages 8905.
Crossref
Fangmei Fu, Xudong Yang, Minying Zheng, Qi Zhao, Kexin Zhang, Zugui Li, Hao Zhang & Shiwu Zhang. (2020) Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer. Frontiers in Molecular Biosciences 7.
Crossref
Lin Gan, Huachao Yang, Zhifeng Xiong, Zailiang Yang, Ting Wang & Gang Lyu. (2020) miR-518a-3p Suppresses Triple-Negative Breast Cancer Invasion and Migration Through Regulation of TMEM2. Technology in Cancer Research & Treatment 19, pages 153303382097752.
Crossref